Skip to main content
 

Our Zofran News

Tuesday, April 21, 2015

In 2012, U.K.-based pharmaceutical company GlaxoSmithKline (GSK) paid $1 billion to resolve criminal charges (misbranding two products and failing to report safety data on another). The company…

Subscribe to Zofran News